Taiwan CBD and Cannabis Regulation Report 2022: No Changes Appears to be Imminent in the Regulatory Environment – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Taiwan: CBD and Cannabis Regulation 2022” report has been added to ResearchAndMarkets.com’s offering.

This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis in Taiwan, covering all policy areas from cultivation and processing to extracts, finished products and import/export.

The growing of hemp for any purpose, including the extraction of CBD, is prohibited in Taiwan by the Narcotics Hazard Prevention Act.

No change appears to be imminent in the regulatory environment for hemp in Taiwan. Although the public has called on the authorities to legalise medical cannabis, it is unlikely to happen in the near future.

Key Topics Covered:

1 Executive summary

2 Outlook

3 Hemp plant

4 Extracts as finished products

5 Finished products containing CBD and extracts

6 Import and export

7 Medical cannabis

8 Recreational cannabis

9 Relevant laws

10 Relevant bodies

For more information about this report visit https://www.researchandmarkets.com/r/wgl3zg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900